Year: 2022

Publication on November 17, 2022, before market openingRegulated and inside information – Business update 3Q22EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS Q3 2022 business update Liège, Belgium, November 17th, 2022 Strong commercial performance continues to fuel growth Record order intake and secured sales continue to confirm the growth path of the company. HighlightsThe order intake confirms the growth trajectory of EVS. Even excluding the Big Tech 2022 contract, the growth is of +39,0% (BER not taken into account). In addition, the order intake for 2022 is strong across all regions. Big Tech contract 2022, a landmark in the history of EVS, signed in August 2022. Our secured revenue* allows us to upgrade our revenue guidance for 2022 to a range of EUR 145 million to EUR 150 million,...

SOUTH SAN FRANCISCO, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced the pricing of its underwritten public offering of 22,613,307 shares of its common stock at a price to the public of $2.60 per share and, to certain investors in lieu of common stock, pre-funded warrants to purchase up to an aggregate of 6,236,693 shares of its common stock at a purchase price of $2.599 per each pre-funded warrant, which represents the per share public offering price for the common stock less the $0.001 per share exercise price for each such pre-funded warrant. All of the securities are to be sold by Tenaya. In addition, Tenaya...

RENO, Nev., Nov. 16, 2022 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE: ORA) (“Ormat”), a leading geothermal, energy storage, solar PV and recovered energy power company, announced today the pricing of an upsized underwritten secondary offering of 3,750,000 shares of its common stock on behalf of ORIX Corporation at a price of $90.00 per share. The offering is expected to close on November 21, 2022, subject to customary closing conditions. Ormat is not offering any of its common stock in the offering for its own account and will not receive any proceeds from the sale of the shares being offered by the selling stockholder. BofA Securities and J.P. Morgan are acting as joint book-running managers for the offering. Wolfe | Nomura Alliance, Citigroup, Cowen, Oppenheimer & Co., Roth Capital Partners, and UBS Investment Bank...

VALENCIA, Calif. and MELBOURNE, Australia, Nov. 16, 2022 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, CEO, and Michael Holder, CFO, on November 23, 2022 at 4:00pm (PST) / November 24, 2022 at 11:00am (AEDT). The webinar will cover highlights from AVITA Medical’s successful September 2022 quarter with commercial revenue up 30% compared to the corresponding period in the prior year, updates to its developmental pipeline, company goals for the next 24 to 36 months, and conclude with Q&A. To register for the presentation, please follow...

ResMed Tuas Facility Ribbon Cutting From to left to right: Brendan Mullins, Vice President of Manufacturing, ResMed; William Hodgman, Australian High Commissioner to Singapore; Jonathan Kaplan, United States Ambassador to Singapore; Peter Farrell, Chairman, ResMed; Mick Farrell, Chief Executive Officer, ResMed; Mr Tharman Shanmugaratnam, Senior Minister, Singapore; Tan Kong Hwee, Executive Vice President, Economic Development Board; Rob Douglas, President and Chief Operating Officer, ResMed; Andrew Price, President of Global Operations, ResMed; Naji Chalhoub, Vice President of Manufacturing, ResMed.ResMed Tuas Advanced Manufacturing Centre – Front View ResMed Tuas Advanced Manufacturing Centre – Front ViewResMed Tuas Advanced Manufacturing Centre – Rear View ResMed Tuas Advanced Manufacturing Centre – Rear...

Toronto, Ontario, Nov. 16, 2022 (GLOBE NEWSWIRE) — Canada Carbon Inc. (the “Company” or “Canada Carbon” or “CCB”) (TSX-V:CCB),(FF:U7N1) is very pleased to announce an updated Mineral Resource Estimate for its flagship 100% owned Miller Graphite Project located 80 kilometres (“km”) west of Montréal, near Grenville Sur-la-Rouge, Québec. The Resource Estimate was prepared pursuant to Canadian Securities Administrators’ National Instrument 43-101 (“NI 43-101”) by the independent firm SGS Canada Inc. (“SGS”) of Blainville, Quebec. The updated Resource Estimate includes an indicated resource of 3.34Mt (“million tonnes”) with an average grade of 0.75% Cg, and an inferred resource of 10.48Mt with an average grade of 0.72% Cg, within the boundaries of an optimized open pit model. The new pit constrained...

OTTAWA, Nov. 16, 2022 (GLOBE NEWSWIRE) — Leonovus Inc., (“Leonovus”) (TSXV: LTV) announces the filing of its unaudited Interim Financial Statements and Management Discussion and Analysis (“MD&A”) for the quarter ended September 30, 2022. Our MD&A contains a comprehensive discussion of Leonovus’ financial position and results of operations and is available on SEDAR at www.sedar.com. Amounts are in Canadian dollars. Torozo (www.torozo.com) continues to perform well for customers. A ‘secure inbox’ with a secure mail link was one of two new features added to Torozo over the last few months. The secure inbox provides users with the capability to mail a link for a secure upload from anyone without having to create a Torozo account. ‘Spaces’ was the second new feature added. Spaces provides policy-based capabilities to folders,...